Sun Pharma has acquired Organon & Co for $11.75 billion. This deal provides Sun Pharma with expanded global scale and commercial reach. It also offers diversification into new segments like women’s health and biosimilars. The acquisition is expected to strengthen Sun Pharma’s position for future growth. Managing integration and debt will be key.Read More
Indian stock markets ended a three-day losing streak with a gain of 0.8 percent on Monday. This rise followed positive movements in Asian markets. Investors showed buying interest in heavyweights like Reliance Industries and Sun Pharmaceuticals. All sectoral indices closed higher. The India VIX volatility index saw a decrease. Foreign portfolio investors sold shares, while domestic institutional investors bought shares.Read More
Axis Bank shares fell 3% despite analysts maintaining a positive outlook, with 94% recommending ‘Buy’. The bank’s loan growth was strong, but provisions for the West Asia conflict rose significantly, impacting performance. Management’s cautious approach to strengthening provisions, while improving asset quality, led to higher credit costs.Read More
Kotak Mahindra Asset Management Co. has approached the Supreme Court challenging a Securities Appellate Tribunal order that upheld SEBI’s findings against it regarding investments made by six fixed maturity plans in Essel Group companies. The tribunal had previously confirmed SEBI’s penalties for regulatory lapses and delayed payouts, though it set aside a fee disgorgement order.Read More
Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Donec sed odio dui. Etiam porta sem malesuada.
